Search

Search Constraints

You searched for: Author/Creator Cook, Stuart

Search Results

1. 015  Reduced risk of secondary progressive multiple sclerosis by treatment with clad- ribine tablets: CLARITY study analysis. Issue 6 (27th May 2022)

2. 022  Updated safety of cladribine tablets in multiple sclerosis patients: integrated safety analysis and post-approval data. Issue 6 (27th May 2022)

3. 039 Rates of lymphopenia in years 1–4 in patients with relapsing multiple sclerosis treated annually with cladribine tablets. Issue 6 (24th May 2018)

4. 040 An analysis of malignancy risk in the clinical development programme of cladribine tablets in patients with relapsing multiple sclerosis. Issue 6 (24th May 2018)

5. 067 Efficacy of cladribine tablets in patients with highly active relapsing-remitting multiple sclerosis: analysis of pooled double-blind data from the clarity and onward studies. Issue 6 (24th May 2018)

6. 121 Re-evaluating the genetic contribution of monogenic dilated cardiomyopathy. (May 2019)

7. 125 Evaluation of titin cardiomyopathy in patients with dilated cardiomyopathy reveals a blunted hypertrophic response, an early arrhythmic risk and a significant interaction with alcohol. (5th June 2017)

8. 127 Relationship between plasma concentrations of b-type natriuretic peptide and exercise capacity in hypertrophic cardiomyopathy. (5th June 2017)